Expansion of the prognostic assessment of patients with chronic obstructive pulmonary disease: the updated BODE index and the ADO index
暂无分享,去创建一个
Ulrike Held | Milo A Puhan | Gerben ter Riet | Judith Garcia-Aymerich | F. Gómez | R. Rodríguez-Roisín | A. Agustí | M. Puhan | G. Riet | K. Moons | J. Garcia-Aymerich | A. Kessels | J. Antó | U. Held | M. Frey | Martin Frey | Alphons G Kessels | Karel GM Moons | Josep M Antó | Alvar G Agustí | Federico P Gómez | Roberto Rodríguez-Roisín
[1] Ewout W Steyerberg,et al. Internal and external validation of predictive models: a simulation study of bias and precision in small samples. , 2003, Journal of clinical epidemiology.
[2] J. Garcia-Aymerich,et al. Caracterización fenotípica y evolución de la EPOC en el estudio PAC-COPD: diseño y metodología , 2009 .
[3] Ralph B D'Agostino,et al. Presentation of multivariate data for clinical use: The Framingham Study risk score functions. , 2005, Statistics in medicine.
[4] J. Copas,et al. Using regression models for prediction: shrinkage and regression to the mean , 1997, Statistical methods in medical research.
[5] D G Altman,et al. What do we mean by validating a prognostic model? , 2000, Statistics in medicine.
[6] Judith Garcia-Aymerich,et al. Phenotypic Characterization and Course of Chronic Obstructive Pulmonary Disease in the PAC-COPD Study: Design and Methods , 2009 .
[7] Yvonne Vergouwe,et al. Prognosis and prognostic research: Developing a prognostic model , 2009, BMJ : British Medical Journal.
[8] P. Royston,et al. Prognosis and prognostic research: application and impact of prognostic models in clinical practice , 2009, BMJ : British Medical Journal.
[9] Xilin Yang,et al. Development and validation of an all-cause mortality risk score in type 2 diabetes. , 2008, Archives of internal medicine.
[10] Gordon H Guyatt,et al. Self-administration and interviewer-administration of the German Chronic Respiratory Questionnaire: instrument development and assessment of validity and reliability in two randomised studies , 2004, Health and quality of life outcomes.
[11] S. Imfeld,et al. The BODE index after lung volume reduction surgery correlates with survival. , 2006, Chest.
[12] P. Royston,et al. Selection of important variables and determination of functional form for continuous predictors in multivariable model building , 2007, Statistics in medicine.
[13] T. Stijnen,et al. Review: a gentle introduction to imputation of missing values. , 2006, Journal of clinical epidemiology.
[14] G. Riet,et al. COPD: more than respiratory , 2008, The Lancet.
[15] J. Gibbs,et al. JBS 2: Joint British Societies' guidelines on prevention of cardiovascular disease in clinical practice , 2005, Heart.
[16] S. Kalra,et al. INTERVAL VERSUS CONTINUOUS HIGH-INTENSITY EXERCISE IN CHRONIC OBSTRUCTIVE PULMONARY DISEASE: A RANDOMIZED TRIAL , 2007 .
[17] M. Tsukino,et al. Analysis of the factors related to mortality in chronic obstructive pulmonary disease: role of exercise capacity and health status. , 2003, American journal of respiratory and critical care medicine.
[18] R. Rodríguez-Roisín,et al. Toward a consensus definition for COPD exacerbations. , 2000, Chest.
[19] G. Guyatt,et al. Interpretation of treatment changes in 6-minute walk distance in patients with COPD , 2008, European Respiratory Journal.
[20] B. Celli,et al. C-reactive protein levels and survival in patients with moderate to very severe COPD. , 2008, Chest.
[21] K. Rabe,et al. From COPD to chronic systemic inflammatory syndrome? , 2007, The Lancet.
[22] H. Kerstjens,et al. Health-related quality of life in COPD patients with chronic respiratory failure , 2008, European Respiratory Journal.
[23] Hans C. van Houwelingen,et al. Validation, calibration, revision and combination of prognostic survival models , 2000 .
[24] F. Gómez,et al. Characteristics of patients admitted for the first time for COPD exacerbation. , 2009, Respiratory medicine.
[25] J. Steurer,et al. Prediction of first coronary events with the Framingham score: a systematic review. , 2007, American heart journal.
[26] B. Celli,et al. The modified BODE index: validation with mortality in COPD , 2008, European Respiratory Journal.
[27] J Marrugat,et al. An adaptation of the Framingham coronary heart disease risk function to European Mediterranean areas , 2003, Journal of epidemiology and community health.
[28] ATS statement: guidelines for the six-minute walk test. , 2002, American journal of respiratory and critical care medicine.
[29] D. Mannino,et al. Global burden of COPD: risk factors, prevalence, and future trends , 2007, The Lancet.
[30] N. Anthonisen,et al. Circulating fibronectin to C-reactive protein ratio and mortality: a biomarker in COPD? , 2008, European Respiratory Journal.
[31] D E Grobbee,et al. External validation is necessary in prediction research: a clinical example. , 2003, Journal of clinical epidemiology.
[32] Y Vergouwe,et al. Updating methods improved the performance of a clinical prediction model in new patients. , 2008, Journal of clinical epidemiology.
[33] Diabetes Uk,et al. JBS 2: Joint British Societies9 guidelines on prevention of cardiovascular disease in clinical practice , 2005 .
[34] J. Curtis,et al. Longitudinal change in the BODE index predicts mortality in severe emphysema. , 2008, American journal of respiratory and critical care medicine.
[35] B. Celli,et al. The 6‐min walk distance: change over time and value as a predictor of survival in severe COPD , 2004, European Respiratory Journal.
[36] W. Howard. Prediction of first coronary events with the Framingham score: A systematic review , 2008 .
[37] W. MacNee,et al. Standards for the diagnosis and treatment of patients with COPD: a summary of the ATS/ERS position paper , 2004, European Respiratory Journal.
[38] Yvonne Vergouwe,et al. Prognosis and prognostic research: validating a prognostic model , 2009, BMJ : British Medical Journal.
[39] M. Becklake,et al. Relationship between chronic dyspnea and expiratory flow limitation in patients with chronic obstructive pulmonary disease. , 1996, American journal of respiratory and critical care medicine.
[40] Ciro Casanova,et al. The body-mass index, airflow obstruction, dyspnea, and exercise capacity index in chronic obstructive pulmonary disease. , 2004, The New England journal of medicine.
[41] H C van Houwelingen,et al. Validation, calibration, revision and combination of prognostic survival models. , 2000, Statistics in medicine.
[42] Ewout W Steyerberg,et al. Validation and updating of predictive logistic regression models: a study on sample size and shrinkage , 2004, Statistics in medicine.
[43] Yvonne Vergouwe,et al. Prognosis and prognostic research: what, why, and how? , 2009, BMJ : British Medical Journal.
[44] Bartolome Celli,et al. Salmeterol and fluticasone propionate and survival in chronic obstructive pulmonary disease. , 2007, The New England journal of medicine.